Chris Jackson is an angel investor and operator angel based in New York, United States. The known portfolio counts 58 companies, including Carisma Therapeutics, GenSight Biologics, Fusion Pharmaceuticals, Precirix, Pulmonx, Altimmune, Aprea, Oncorena, Aro Biotherapeutics, Doctrin, Modus Therapeutics and Nexstim.
Is Chris Jackson a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Stage
- Seed
- Sector
- AIHealthcare
Contacts
Chris Jackson portfolio companies (58)
- Carisma Therapeutics
- GenSight Biologics
- Fusion Pharmaceuticals
- Precirix
- Pulmonx
- Altimmune
- Aprea
- Oncorena
- Aro Biotherapeutics
- Doctrin
- Modus Therapeutics
- Nexstim
- PTC Therapeutics
- Sopherion Therapeutics
- Tengion
- Ultragenyx Pharmaceutical
- Vivet Therapeutics
- Algeta
- BONESUPPORT
- ChemoCentryx
- Five Prime Therapeutics
- Idea
- Renovo
- Spruce Biosciences
- Strongbridge Biopharma
- Wilson Therapeutics
- Actelion Pharmaceuticals
- Alba Therapeutics
- Arpida AG
- BeneChill
- BioStratum
- Biolipox
- Bionaut Pharmaceuticals
- Cardoz
- CoreValve
- Cytos
- Dynavax Technologies
- FerroKin Biosciences
- Glionova
- Gyros
Showing 40 of 58 known investments. Full portfolio in the app.
Investor Profile
Founders in the listed sectors AI and Healthcare, and focus areas Biotech, Clinical Trials, Diagnostics and MedTech will recognize the pattern in this portfolio.
Stage-wise, the known deals cluster around Seed rounds.
Reviewing the investment history helps decide whether there is a realistic fit before reaching out.
Similar investors
Showing 20 of 97
Jeffrey Kaditz
angel investor
Jannah Boudreaux
angel investor
Los Angeles, United States
Gyuri Karady
Angel Investor
Montreal, Canada
Ted Love
operator angel
Keith Valentine
angel investor and operator angel
San Diego, United States
Yoni Goldwasser
Co-Founder & Managing Director, Angel Investor
Berlin, Germany
Andrew Marciniec
angel investor
Malta
Barbara Lubash
angel investor
Orange County, United States
Andrew Sandford
angel investor
Boston, United States
Andrew Eshelman
angel investor
Chicago, United States
Peter Letmathe
operator angel
David Wiersma
angel investor
Tucson, United States
Steven Berger
operator angel
Yury Kukushkin
angel investor
Boston, United States
Jacques Essinger
angel investor and operator angel
Lausanne, Switzerland
Juliana Garaizar
operator angel
Houston, United States
Jesse Rasch
angel investor
Toronto, Canada
Robin Stracey
angel investor and operator angel
Reno, United States
Jeroen Siemes
angel investor and operator angel
Tilburg, Netherlands
David Lamond
operator angel
Frequently asked questions
Who is Chris Jackson?
Chris Jackson is an angel investor and operator angel based in New York, United States with 58 known investments on file, among them Carisma Therapeutics, GenSight Biologics and Fusion Pharmaceuticals. The sections above list the sectors and stages attached to that record.
What does Chris Jackson invest in?
Listed sectors include AI and Healthcare; listed focus areas include Biotech, Clinical Trials, Diagnostics and MedTech. Those tags come from the companies attached to this profile, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Chris Jackson invest at?
The known deals of Chris Jackson include Seed rounds. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
How do I contact Chris Jackson?
An email address, a phone number and a LinkedIn page are on file for Chris Jackson. The address stays masked on this page and is readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal